UV/Optical Nuclear Activity in the gE Galaxy NGC 1399

Autor: O'Connell, R. W., Martin, J. R., Crane, J. D., Burstein, D., Bohlin, R. C., Landsman, W. B., Freedman, I., Rood, R. T.

Publikováno v: Astrophys.J.635:305-310,2005

Using HST/STIS, we have detected far-ultraviolet nuclear activity in the giant elliptical galaxy NGC 1399, the central and brightest galaxy in the Fornax I cluster. The source reached a maximum observed far-UV luminosity of \~1.2 x 10e39 ergs/s in Ja

Externí odkaz: http://arxiv.org/abs/astro-ph/0509311

The Silver Bowl

Autor: Freedman, I.

Publikováno v: The Jewish Quarterly Review, 1896 Apr 01. 8(3), 534-540.

Externí odkaz: https://www.jstor.org/stable/1450091

Estimating parameters of nonlinear dynamic systems in pharmacology using chaos synchronization and grid search

Autor: Pillai, N. Schwartz, S.L. Ho, T. Dokoumetzidis, A. Bies, R. Freedman, I.

Bridging fundamental approaches to model optimization for pharmacometricians, systems pharmacologists and statisticians is a critical issue. These fields rely primarily on Maximum Likelihood and Extended Least Squares metrics with iterative estimatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0305188fad39b64bd50eda6b5eefeb26
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3021501

Chaos synchronization and Nelder-Mead search for parameter estimation in nonlinear pharmacological systems: Estimating tumor antigenicity in a model of immunotherapy

Autor: Pillai, N. Craig, M. Dokoumetzidis, A. Schwartz, S.L. Bies, R. Freedman, I.

In mathematical pharmacology, models are constructed to confer a robust method for optimizing treatment. The predictive capability of pharmacological models depends heavily on the ability to track the system and to accurately determine parameters wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::60cf042dab85290ed4fedc06641406ad
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3087131

ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors

Autor: Mcgeoch, A., van Oordt, C. Menke-van der Houven, Bergstrom, M., McSherry, I., Smith, D., Cleveland, M., Hoekstra, O., Vugts, D., Weber, A., Freedman, I., Huisman, M., Matheny, C., van Dongen, G., Zhang, S.

Publikováno v: Mcgeoch, A, van Oordt, C M D H, Bergstrom, M, McSherry, I, Smith, D, Cleveland, M, Hoekstra, O, Vugts, D, Weber, A, Freedman, I, Huisman, M, Matheny, C, van Dongen, G & Zhang, S 2017, ' ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 44, pp. S314-S315 .
European Journal of Nuclear Medicine and Molecular Imaging, 44, S314-S315. Springer Verlag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5ad133910de30e8336c151d1cb0becca
https://research.vumc.nl/en/publications/f11bd120-9eba-4c6f-abb8-44bef0532c71